富力(02777.HK):「16富力04」持有人會議審議通過展期兌付等議案
富力地產(02777.HK)公佈,於昨日(6日)舉行的2016年公司債券(第三期)(品種一)債券持有人會議中,《關於豁免本期債券持有人會議通知期限、豁免臨時提案提交及公告期限的議案》獲得76.59%的同意;《關於給予「16富力04」30日兌付寬限期的議案》獲76.27%同意;《關於調整「16富力04」兌付方案及提供增信措施的議案》獲73.26%同意;《關於承諾「不逃廢債」的議案》獲76.99%同意。
是次出席的債券持有人或其代理人共計143名,代表有表決權的本期債券1,483.89萬張,佔「16富力04」有表決權債券總張數的77.18%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.